THE EXPRESSION OF PARATHYROID HORMONE-RELATED PROTEIN IN HUMAN BREAST-CANCER WITH SKELETAL METASTASES

被引:36
作者
KOHNO, N
KITAZAWA, S
FUKASE, M
SAKODA, Y
KANBARA, Y
FURUYA, Y
OHASHI, O
ISHIKAWA, Y
SAITOH, Y
机构
[1] The Department of Surgery, Hyogo Medical Center for Adults, Akashi, 651
[2] The Second Department of Pathology, Kobe University School of Medicine, Kobe, 650, Kusunoki-cho 7-5-2, Chuo-ku
[3] The Third Division of Internal Medicine, Kobe University School of Medicine, Kobe, 650, Kusunoki-cho 7-5-2, Chuo-ku
[4] The First Department of Surgery, Kobe University School of Medicine, Kobe, 650, Kusunoki-cho 7-5-2, Chuo-ku
来源
SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY | 1994年 / 24卷 / 03期
关键词
PARATHYROID HORMONE-RELATED PROTEIN; BREAST CANCER; SKELETAL METASTASES;
D O I
10.1007/BF02032890
中图分类号
R61 [外科手术学];
学科分类号
摘要
The relationship between the expression of parathyroid hormone-related protein (PTHrP) by breast cancer and skeletal metastases, was investigated using a monoclonal antibody against human PTHrP (4B3). The immunohistochemical localization of PTHrP was studied in sections of formalin-fixed, paraffin-embeded tissues from 28 breast cancers obtained surgically between 1980 and 1985. Of the 28 patients, 12 developed skeletal metastases, 8 developed lung metastases, and the other 8 were alive and disease-free at the time of this study. Sixteen of the 28 (57%) tumors showed positive immunoreactivity to 4B3, the PTHrP positive ratio being 83% in the patients who developed skeletal metastases, 38% in those who developed lung metastases, and 38% in those without recurrence, respectively. Thus, a significantly higher proportion of the patients who developed skeletal metastases were positive for PTHrP than the other two groups (P < 0.05). Furthermore, the level of positive staining was strongly related to positivity for estrogen and progesterone receptors (P < 0.01). These results are consistent with the hypothesis that PTHrP might be necessary for metastases to erode bone and grow in skeletal sites, and its expression could be related to certain hormones.
引用
收藏
页码:215 / 220
页数:6
相关论文
共 22 条
[1]  
Galasko C.S.B., Mechanism of bone destruction in the development of skeletal metastases, Nature, 263, pp. 507-508, (1976)
[2]  
Mundy G.R., Martin T.J., The hypercalcemia of malignancy: Pathogenesis and management, Metabolism, 31, pp. 1247-1227, (1983)
[3]  
Suva L.J., Winslow G.A., Wettenhall R.E.H., Hammonds R.G., Mosley J.M., Jagger H.D., Rodda C.P., Kemp B.E., Rodriguez H., Chen E.Y., Hudson P.J., Martin T.J., Wood W.I., A parathyroid hormonerelated protein implicated in malignant hypercalcemia: Cloning and expression, Science, 237, pp. 893-896, (1987)
[4]  
Manngin M., Webb A.C., Dreyer B.E., Posillico J.T., Ikeda K., Weir E.C., Stewart A.F., Bander N.H., Milstone L., Barton D.E., Francke U., Broadus A.E., Identification of a cDNA encoding a parathyroid hormone-like peptide from a human tumor associated with humoral hypercalcemia of malignancy, Proceedings of the National Academy of Sciences, 85, pp. 597-601, (1988)
[5]  
Stewert A.F., Wu T., Goumas D., Burtis W.J., Broadus A.E., N-adenylcyclase-stimum terminal amino acid sequence of two novel tumor-derived adenylate cyclase-stimulating proteins: Identification of parathyroid hormone-like and parathyroid hormone unlike domains, Biochemical and Biophysical Research Communications, 146, pp. 672-678, (1987)
[6]  
Strewler G.J., Stem P.H., Jacobs J.W., Eveloff J., Klein R.F., Leung S.C., Roenblatt M., Nissenson R.A., Parathyroid hormonelike protein from human renal carcinoma cells structural and functional homology with parathyroid hormone, J Clin Invest, 80, pp. 1803-1807, (1987)
[7]  
Southby J., Kissin M.W., Danks J.A., Hayman J.A., Moseley J.M., Henderson M.A., Bennett R.C., Martin T.J., Immunohistochemicallocalization of parathyroid hormone-related protein in human breast cancer, Cancer Res, 50, pp. 7710-7716, (1990)
[8]  
Kitazawa S., Fukase M., Kitazawa R., Takenaka A., Gotoh A., Fujita T., Maeda S., Immunohistological evaluation of parathyroid hormone-related protein (PTHrP) in human lung cancer and normal tissue with newly developed monoclonal antibody, Cancer, 67, pp. 984-989, (1991)
[9]  
Kohler G., Milstein C., Continuous cultures of fused cells secreting of predefined specificity, Nature, 256, pp. 495-497, (1975)
[10]  
Thomus A.N., Loken H.F., Goldman L., Hypercalcemia of metastatic breast cancer, Surg Forum, 16, pp. 70-71, (1960)